Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.

Urology Update 2017: For Primary Care and Advanced Practice Providers

Saturday, May 13, 2017
Boston Convention and Exhibition Center, Room 210C
415 Summer Street
Boston, MA 02210

Pre-registration is now closed. Onsite registration will be available. To expedite your onsite registration experience, please print and complete the attached Attendee Registration Form and bring it with you to the course.

Course Director: Howard N. Winfield, MD

Target Audience: Internists, family practitioners, nurse practitioners, physician assistants, allied healthcare professionals and other primary healthcare professionals

We invite you to attend this complimentary CME activity (pre-registration required) with the latest research from the experts on the urologic issues most relevant to front-line patient care. This program will provide primary healthcare professionals, advanced practice providers and allied healthcare professionals practical knowledge that will allow them to respond effectively to the needs of patients with urologic diseases. This free, half-day course will enhance your knowledge to help improve patient care in the following areas while focusing on the review of AUA Guidelines:

  • Prostate Cancer
  • Bladder Cancer
  • Renal Cancer
  • Stress Uriniary Incontinence (SUI)
  • Overactive Bladder (OAB)
  • Nocturia
  • Bladder Pain Syndrome/Interstitital Cystitis (IC)

Program Agenda

6:30 – 7:30 a.m.

Registration

7:30 – 7:35 a.m.

Introduction
Howard N. Winfield, MD

7:35 – 7:50 a.m.

Pre-test
Howard N. Winfield, MD

Session I: Oncology

7:50 – 8:30 a.m.

Prostate Cancer – Why all the Controversy?
Howard N. Winfield, MD

8:30 – 9:00 a.m.

Bladder Cancer – The Dangerous Lurking Malignancy
Michael O'Donnell, MD

9:00 – 9:25 a.m.

Renal Cancer – The Internist's Disease in the Era of CT Scanning
David S. Wang, MD

9:25 – 9:40 a.m.

Panel Discussion: When to Refer?
Jason Worcester, MD; Howard N. Winfield, MD; Michael O'Donnell, MD; David S. Wang, MD

9:40 – 9:55 a.m.

Break

 

Session II: Voiding Dysfunction

9:55 – 10:15 a.m.

Stress Urinary Incontinence – Evaluation and Management Strategies
Matthew Thom, MD

10:15 – 10:55 a.m.

Overactive Bladder – Making and Setting Expectations for Treatment Selection
Matthew Thom, MD

10:55 – 11:15 a.m.

Nocturia – Important Considerations and Management Strategies
Sandip Vasavada, MD

11:15 a.m. – 11:45 a.m.

Bladder Pain Syndrome/Interstitial Cystitis – Females 
Sandip Vasavada, MD

11:45 a.m. – Noon

Panel Discussion: When to Refer?
Jason Worcester, MD; Matthew Thom, MD; Sandip Vasavada, MD

Noon – 12:15 p.m.

Post-test/Wrap-up
Howard N. Winfield, MD

12:15 p.m.

Adjourn

This program takes place during the AUA's 2017 Annual Meeting. Attendees of this course will be allowed access to the Science & Technology Hall following the course where they can explore the latest advances and technologies in urologic medicine.

Learning Objectives

After attending this course, participants will be able to:

Prostate Cancer

  • Discuss the epidemiology and genetic factors
  • Describe the PSA controversy and AUA guideline recommendations
  • Identify the diagnostic methods of staging and grading of prostate cancer
  • Review the treatment options for localized and advanced cancer
  • Effectively utilize the AUA Guidelines

Bladder Cancer

  • Discuss the epidemiology and risk factors
  • Identify the diagnostic methods of staging and grading of bladder cancer
  • Describe the use of Intravesical therapy for non-invasive bladder cancer
  • Compare treatment options for muscle invasive bladder cancer – surgical, radiotherapy, and chemotherapy
  • Effectively utilize the AUA Guidelines

Renal Cancer

  • Discuss the epidemiology and genetic risk factors
  • Review the treatment options for renal cell cancer and transitional cell kidney cancer
  • Discuss new and exciting chemotherapeutic treatment options for advanced renal cell carcinoma
  • Effectively utilize the AUA Guidelines

Stress Urinary Incontinence

  • Explain the etiology of stress incontinence in women and associated comorbidities
  • Outline appropriate evaluation for stress incontinence
  • Review current treatment options available for stress incontinence and when to refer
  • Effectively utilize the AUA Guidelines

Overactive Bladder

  • Outline a stepwise evaluation for the patient with overactive bladder
  • Describe management options for OAB including pharmacotherapy, onabotulinumtoxinA and Neuromodulation according to AUA/SUFU guidelines
  • Determine when it is appropriate to refer to a specialist
  • Effectively utilize the AUA Guidelines

Nocturia

  • Identify common causes and comorbidities associated with nocturia
  • Describe the baseline evaluation and appropriate testing for initial work up of nocturia
  • Outline various treatment options for nocturia including when to initiate referral to an appropriate specialist

Bladder Pain Syndrome/Interstitial Cystitis – Females

  • Discuss the diagnosis and treatment of interstitial cystitis
  • Identify the associated organ systems involved with chronic pelvic pain
  • Effectively utilize the AUA Guidelines

Additional Information

Hotel Information

Find out more information about hotel and travel options

Parking Information

If driving, please read the information on parking at the Boston Convention & Exhibition Center.

About the American Urological Association

Throughout our 100-year history, the AUA has dedicated itself to promoting the highest standards of urological clinical care through education, research and health policy.

We recognize that primary care providers are often the first stop in diagnosing patients with symptoms of urologic conditions and diseases.

View more information on educational opportunities for Primary Care Providers

Accreditation

The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.

Credit Designation

The AUA designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAFP Accreditation

This live activity, Urology Update 2017: For Primary Care and Advanced Practice Providers, with a beginning date of 5/13/2017, has been reviewed and is acceptable for up to 4.50 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation for Physician Assistants

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 4.5 hours of Category I credit for completing this program.

advertisement

advertisement